25.03.2024 12:20 | IMM | Incanthera says first order from skincare deal doubles | Alliance |
25.03.2024 10:55 | AEO, IMM, CASP | AIM WINNERS & LOSERS: ImmuPharma order doubles; Aeorema swings to loss | Alliance |
25.03.2024 07:25 | IMM | Incanthera provides Comm'l Update/Revenue F'casts | RNS |
19.03.2024 07:00 | IMM | Grant of Share Options | RNS |
14.03.2024 07:00 | IMM | IMMUPHARMA AT BIO-EUROPE SPRING 2024 | Reach |
06.03.2024 13:05 | NET, RCDO, AEG | EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up | Alliance |
06.03.2024 07:00 | IMM | Financial, Business and Portfolio Develop't Update | RNS |
28.12.2023 13:35 | IMM | Holding(s) in Company | RNS |
19.12.2023 17:52 | PCIP, IMM, TIME | EARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrows | Alliance |
19.12.2023 14:50 | IMM | Holding(s) in Company | RNS |
19.12.2023 07:00 | IMM | Simbec-Orion appointed as CRO | RNS |
18.12.2023 12:18 | IMM | IN BRIEF: Incanthera signs skincare stocking deal, raises GBP1 million | Alliance |
18.12.2023 07:15 | IMM | Incanthera - Comm'l Skincare Deal/£1M Fundraise | RNS |
13.09.2023 15:47 | IMM | Holding(s) in Company | RNS |
07.09.2023 17:07 | RAI, CGI, AREC | TRADING UPDATES: RA International loss narrows as revenue grows | Alliance |
07.09.2023 07:00 | IMM | Result of Retail Offer and Director Shareholding | RNS |
06.09.2023 13:53 | IMM | Holding(s) in Company | RNS |
31.08.2023 13:05 | IMM | ImmuPharma launches GBP2 million fund raise as interim loss narrows | Alliance |
31.08.2023 07:02 | IMM | WRAP Retail Offer for up to £0.5m | RNS |
31.08.2023 07:01 | IMM | Subscription to raise £1.35m; Sharing Agr, RPT | RNS |
31.08.2023 07:00 | IMM | Interim results | RNS |
21.08.2023 12:33 | IMM | ImmuPharma agrees 12 month extension to Incanthera warrant instrument | Alliance |
21.08.2023 07:00 | IMM | Extension of warrants in Incanthera plc | RNS |
11.08.2023 12:04 | IMM | Directorate Change | RNS |
30.06.2023 13:12 | IMM | Result of AGM | RNS |
23.06.2023 15:51 | CHSS, URAH, STG | UK shareholder meetings calendar - next 7 days | Alliance |
19.06.2023 12:02 | IMM | IN BRIEF: ImmuPharma to start next two phases of Lupuzor trial | Alliance |
19.06.2023 07:00 | IMM | Lupuzor Update | RNS |
06.06.2023 07:00 | IMM | IMM RNS Posting of RA and Notice of AGM 30 June 23 | RNS |
18.05.2023 12:12 | IMM | IN BRIEF: ImmuPharma rises on FDA feedback for neurological disease | Alliance |
18.05.2023 07:00 | IMM | Positive Pre-IND meeting with FDA | RNS |
11.05.2023 11:48 | IMM | IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced | Alliance |
10.05.2023 13:56 | IMM | Holding(s) in Company | RNS |
19.04.2023 15:40 | IMM | IN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meeting | Alliance |
19.04.2023 07:00 | IMM | Lupozor Update - FDA confirms Type-C meeting date | RNS |
12.04.2023 11:27 | IMM | IN BRIEF: ImmuPharma shares up as FDA meeting for new drug confirmed | Alliance |
12.04.2023 10:37 | SYS1, IMM, BZT | AIM WINNERS & LOSERS: System1 rises after upturn in second half | Alliance |
12.04.2023 07:00 | IMM | CIDP P140 Clinical Program Update | RNS |
27.03.2023 10:51 | IMM, PRES | AIM WINNERS & LOSERS: ScotGold drops two-thirds as gold grade declines | Alliance |
27.03.2023 10:32 | IMM | ImmuPharma submits phase 2/3 protocol to US FDA for Lupuzor treatment | Alliance |
27.03.2023 07:00 | IMM | Lupuzor™ Update | RNS |
09.03.2023 16:35 | IMM | Price Monitoring Extension | RNS |
06.03.2023 11:22 | IMM | ImmuPharma signs 12-month deal with Orano for use of peptide tech | Alliance |
06.03.2023 07:00 | IMM | Collaboration with Orano on ImmuPharma Peptide | RNS |
06.02.2023 11:37 | IMM | ImmuPharma agrees study design with Avion for lupus programme Lupuzor | Alliance |
06.02.2023 07:00 | IMM | Lupuzor™ Update | RNS |
27.01.2023 16:25 | IMM | TR-1: Notification of major holdings | RNS |
04.01.2023 17:26 | IMM | TR-1: Notification of major holdings | RNS |
04.01.2023 16:40 | IMM | Second Price Monitoring Extn | RNS |
04.01.2023 16:35 | IMM | Price Monitoring Extension | RNS |
03.01.2023 16:58 | IMM | TR-1: Notification of major holdings | RNS |
22.12.2022 21:09 | ICON, POW, IMM | TRADING UPDATES: Ground Rents Income Fund's portfolio value drops | Alliance |
22.12.2022 07:55 | IMM | Grant of Options | RNS |
22.12.2022 07:00 | IMM | End of Year Update | RNS |
22.11.2022 15:15 | IMM | Holding(s) in Company | RNS |
14.11.2022 16:40 | IMM | Second Price Monitoring Extn | RNS |
14.11.2022 16:35 | IMM | Price Monitoring Extension | RNS |
11.11.2022 19:56 | IUG, SLFR, CGH | TRADING UPDATES: Driver records loss; Synectics sells business unit | Alliance |
11.11.2022 07:31 | IMM | Lupuzor Update | RNS |
11.10.2022 16:40 | IMM | Second Price Monitoring Extn | RNS |
11.10.2022 16:35 | IMM | Price Monitoring Extension | RNS |
07.10.2022 16:44 | IMM | Company Secretary Change | RNS |
06.10.2022 20:10 | POLX, EQT, ALGW | TRADING UPDATES: ImmuPharma loss narrows; MetalNRG loss widens | Alliance |
06.10.2022 17:17 | IMM | Holding(s) in Company | RNS |
30.09.2022 07:30 | IMM | Lupuzor Update | RNS |
30.09.2022 07:00 | IMM | Interim Results or the 6mths Ended 30 June 2022 | RNS |
29.09.2022 16:40 | IMM | Second Price Monitoring Extn | RNS |
29.09.2022 16:37 | IMM | Price Monitoring Extension | RNS |
23.09.2022 15:56 | TRLS, STG, PNN | UK earnings, trading statements calendar - next 7 days | Alliance |
14.09.2022 12:46 | IMM | IN BRIEF: ImmuPharma receives response for FDA for Lupuzor | Alliance |
14.09.2022 10:04 | IMM | Written Response received from the FDA | RNS |
07.09.2022 09:55 | IMM | ImmuPharma raises GBP150,000 via issue of 3 million new shares | Alliance |
07.09.2022 08:25 | IMM | Exercise of Options | RNS |
31.08.2022 21:41 | GAL, CCZ, IMM | TRADING UPDATES: ImmuPharma waits on FDA; IDE Group waits on audit | Alliance |
31.08.2022 07:00 | IMM | FDA response for Type C Meeting - update | RNS |